Sanofi’s early Immunology franchise has a diverse portfolio which includes the upcoming late-stage priority asset amlitelimab (OX40L) and early compounds at Proof-of-Concept or earlier stages of development. We are advancing a robust and growing pipeline of multiple indication assets that span a range of therapeutic areas including dermatology, asthma, gastroenterology, nephrology, rheumatology, and many others.
The Global Market Access and Pricing (GMAP) lead will be responsible for access analytics and championing the one-voice market access perspective for pipeline assets throughout the development timeline. This will include providing market access input to support indication selection, clinical development plans at all stages, broader payer data generation efforts, forecasts, and governance meeting, while also developing top-line value messaging to support aspirations and pricing benchmarks.
This is a highly collaborative role that requires a strong cross-functional approach. The GMAP lead will be a core member of the Global Project Team and work closely with a range of functions and business partners (New Product Planning, Clinical, Medical, HEVA, Regulatory, HVT), as well countries where relevant, to fully realize the pricing and access potential of the portfolio.
The role will also entail improving early market access capabilities and planning across key assets in the pipeline through play-to-win behaviors.
Leads the assessment of various internal assets and potential target indications, in collaboration with the therapeutic global cross-functional partners
Leads the development of the access and pricing strategy of internal assets, based on relevant scenarios developed in collaboration with New Product Planning
Responsible for the timely development a clear Early Market Access Roadmap for all assets under scope to ensure the organization has the right level of understanding and preparedness to support decision making and market preparation
Responsible for the timely execution of all core activities pertaining to the following:
Foundational knowledge of disease and payer unmet needs (through conducting secondary and primary payer research where relevant)
Early market access success factors / risks identification
Fact-based early potential assessments (with price/access assumptions for forecasting) and scenario development
Informed market access input to clinical development plan & pivotal trial design
Early market access plan
Early payer value proposition
Payer evidence plan and IEGP support, in partnership with HEVA, to ensure it supports the Payer Value proposition
As part of the GPT and early commercialization team:
Contributes to the formulation and execution of the asset(s) strategy and ensure key payer/ market access considerations are made explicit and are addressed as appropriate (target patient population, clinical endpoints, comparator, etc)
Provides the relevant support for governance meetings (ie, TARC, DWG, IDCC, SPM, etc)
Coordinates the relevant Market Access GLocal subteams, ensuring relevant input and engagement from priority markets
Maintain a high level of knowledge with regards to the scientific, clinical, strategic pricing and commercial developments relevant to the assets under scope
Develop and maintain a robust understanding of relevant pricing and reimbursement criteria used by payers in key markets to make informed decisions about payer strategy, plans and tactics
Improves early market access capabilities across the pipeline through methodology & standard improvement in areas such as value assessment, strategic pricing, robust and early insights generation, scenario development, risk management
CORE BEHAVIORAL COMPETENCIES:
Push to go beyond the level we have operated until now: constantly challenge the status quo focusing on the priorities that will deliver the best outcomes and letting go what won’t: be intolerant to mediocracy, believe we can and must do better and aim at higher but never at the expenses of our values and judgment
Put the interest of the organization ahead of your own or those of your team: consider both short- and long-term impact of decisions; put collective and global goals above individual or local goals; share resources and capabilities with those with the greatest need and impact; enable decision making at appropriate level
Act in the interest of our patients and customers: actively engage with customers to know their current and future needs; bring an external perspective into decisions
Take action and don’t wait to be told what to do: take smart and informed best bets with the information at hand and anticipate the consequences of your actions; use personal judgement and others’ advice to make bold and impactful decisions which move us forward
SKILLS, EXPERIENCE & KNOWLEDGE REQUIREMENTS:
Master’s degree in science, business, or related discipline with >10 years of relevant professional experience with an accomplished track record
Strong interest for clinical drug development / the science and shaping early strategies in a continuously evolving environment
Strong analytical skills, including pricing, with ability to translate clinical information and messages into clear payer access strategies / recommendations
Flexibility and demonstrated ability to work across multiple projects and priorities as well as across diverse and complex payer archetypes in the US and ex-US geographies
Outstanding written and oral communication skills, including the ability to write and deliver presentations to professionals at all levels within Sanofi in a straightforward way
Strong leadership and demonstrated relationship building; ability to work well in a cross-functional team and build coalition
Understanding of the evolution of the market access landscape and implications for the business
Demonstrated business acumen, analytical and financial skills to evaluate investment strategies, and comfortable with product forecast and P&L, quantitative skills
As a healthcare company and a vaccine manufacturer, Sanofi has an important responsibility to protect individual and public health. All US based roles require individuals to be fully vaccinated against COVID-19 as part of your job responsibilities.
According to the CDC, an individual is considered to be “fully vaccinated” fourteen (14) days after receiving (a) the second dose of the Moderna or Pfizer vaccine, or (b) the single dose of the J&J vaccine. Fully vaccinated, for new Sanofi employees, is to be fully vaccinated 14 DAYS PRIOR TO START DATE.
Sanofi Inc. and its U.S. affiliates are Equal Opportunity and Affirmative Action employers committed to a culturally diverse workforce. All qualified applicants will receive consideration for employment without regard to race; color; creed; religion; national origin; age; ancestry; nationality; marital, domestic partnership or civil union status; sex, gender, gender identity or expression; affectional or sexual orientation; disability; veteran or military status or liability for military status; domestic violence victim status; atypical cellular or blood trait; genetic information (including the refusal to submit to genetic testing) or any other characteristic protected by law.
At Sanofi diversity and inclusion is foundational to how we operate and embedded in our Core Values. We recognize to truly tap into the richness diversity brings we must lead with inclusion and have a workplace where those differences can thrive and be leveraged to empower the lives of our colleagues, patients and customers. We respect and celebrate the diversity of our people, their backgrounds and experiences and provide equal opportunity for all.